1. In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes
   Tsang-Pai Liu et al, 2016, Oncoscience CrossRef
2. Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate
   Silvia Udali et al, 2021, Front. Oncol. CrossRef
3. Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data
   Jihad Aljabban et al, 2022, WJGO CrossRef
4. Potential therapeutic molecular targets for better outcomes for patients with lung cancer
   Sean T. Mack et al, 2023, IJMIO CrossRef
5. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells
   Jiraporn Jantaravinid et al, 2024, Sci Rep CrossRef